Chem. Sci., 2023, Advance Article
DOI: 10.1039/D3SC03932C, Edge Article
DOI: 10.1039/D3SC03932C, Edge Article
Open Access
This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Youchao Wang, Pierre Mesdom, Kallol Purkait, Bruno Saubaméa, Pierre Burckel, Philippe Arnoux, Céline Frochot, Kevin Cariou, Thibaud Rossel, Gilles Gasser
Novel sulfonamide-based monopodal and dipodal ruthenium and osmium polypyridyl complexes capable of targeting carbonic anhydrases are a major target in cancer therapy are described as new photosensitizers for photodynamic therapy.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
Novel sulfonamide-based monopodal and dipodal ruthenium and osmium polypyridyl complexes capable of targeting carbonic anhydrases are a major target in cancer therapy are described as new photosensitizers for photodynamic therapy.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry